Top Markets
Coin of the day
H-CYTE, Inc. H-CYTE, Inc.

H-CYTE, Inc.

HCYT
Rank in Stocks #39158
H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated... H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated to developing and supplying a range of treatments for individuals afflicted with persistent respiratory and pulmonary diseases. The company's core strategy involves pioneering and deploying autologous cellular therapy solutions specifically for chronic lung conditions. Additionally, H-CYTE maintains a product supply agreement with Rion, LLC, focused on advancing and distributing a biologic compound designed to combat chronic obstructive pulmonary disease (COPD). Its corporate headquarters are situated in Tampa, Florida.
Share Price
$0.995
Last synced: 2023-07-07
Market Cap
$624.98K
Change (1 day)
-0.50%
Change (1 year)
0.00%
Country
US
Trade H-CYTE, Inc. (HCYT)

Category

Price of HCYT with the market cap of B
H-CYTE, Inc. H-CYTE, Inc.
HCYT
$0.995
Market Capitalization of H-CYTE, Inc.(HCYT)
Market Cap: $624.98K
As of August 2026 H-CYTE, Inc. has a market cap of $624.98K. This makes H-CYTE, Inc. the world's 39158th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of H-CYTE, Inc. from 2014 to 2026
HCYT compared with Top 5 Most Popular stocks
Price of HCYT Asset B Mkt. of B Results
H-CYTE, Inc. H-CYTE, Inc.
$8,707,791 $624.98K
$5.470T +875,154,789.59%
H-CYTE, Inc. H-CYTE, Inc.
$7,111,812 $624.98K
$4.467T +714,754,850.85%
H-CYTE, Inc. H-CYTE, Inc.
$6,645,842 $624.98K
$4.174T +667,923,733.40%
H-CYTE, Inc. H-CYTE, Inc.
$5,890,717 $624.98K
$3.700T +592,031,782.89%
H-CYTE, Inc. H-CYTE, Inc.
$4,544,263 $624.98K
$2.854T +456,709,785.08%